19 VCs and 3 funds investing in Medical Technology
SLP & Venture Partner
Cottonwood Technology Fund
Check: Cottonwood publishes a $1M-$3M first-investment range for seed-stage companies.
Alan Abbott contributes to Cottonwood Technology Fund's published strategy: Lead early rounds in patent-based hard-science and deep-technology companies in the U.S. Southwest and Northern Europe.
Principal
Cottonwood Technology Fund
Check: Cottonwood publishes a $1M-$3M first-investment range for seed-stage companies.
Ytsen van der Meer contributes to Cottonwood Technology Fund's published strategy: Lead early rounds in patent-based hard-science and deep-technology companies in the U.S. Southwest and Northern Europe.
Corporate & Investor Relations
Cottonwood Technology Fund
Check: Cottonwood publishes a $1M-$3M first-investment range for seed-stage companies.
Sabine Jansen contributes to Cottonwood Technology Fund's published strategy: Lead early rounds in patent-based hard-science and deep-technology companies in the U.S. Southwest and Northern Europe.
Technology Analyst
Cottonwood Technology Fund
Check: Cottonwood publishes a $1M-$3M first-investment range for seed-stage companies.
Shinjan Dasgupta contributes to Cottonwood Technology Fund's published strategy: Lead early rounds in patent-based hard-science and deep-technology companies in the U.S. Southwest and Northern Europe.
Investment Analyst
Cottonwood Technology Fund
Check: Cottonwood publishes a $1M-$3M first-investment range for seed-stage companies.
Daan Boekhoudt contributes to Cottonwood Technology Fund's published strategy: Lead early rounds in patent-based hard-science and deep-technology companies in the U.S. Southwest and Northern Europe.
SLP & Venture Partner
Cottonwood Technology Fund
Check: Cottonwood publishes a $1M-$3M first-investment range for seed-stage companies.
Charles Call contributes to Cottonwood Technology Fund's published strategy: Lead early rounds in patent-based hard-science and deep-technology companies in the U.S. Southwest and Northern Europe.
Managing Director
Ohio Innovation Fund
Check: $500K-$4M, as published by Ohio Innovation Fund.
Bill Baumel invests or supports investments through Ohio Innovation Fund's published strategy: Back transformative, disruptive and breakthrough founders in AI, medtech, AR/VR, cybersecurity, SaaS and biotech, while providing hands-on support through key value inflection points.
Venture Partner
Ohio Innovation Fund
Check: $500K-$4M, as published by Ohio Innovation Fund.
Michael Hughes invests or supports investments through Ohio Innovation Fund's published strategy: Back transformative, disruptive and breakthrough founders in AI, medtech, AR/VR, cybersecurity, SaaS and biotech, while providing hands-on support through key value inflection points.
Venture Partner
Ohio Innovation Fund
Check: $500K-$4M, as published by Ohio Innovation Fund.
Mike Triplett invests or supports investments through Ohio Innovation Fund's published strategy: Back transformative, disruptive and breakthrough founders in AI, medtech, AR/VR, cybersecurity, SaaS and biotech, while providing hands-on support through key value inflection points.
Venture Advisor
Ohio Innovation Fund
Check: $500K-$4M, as published by Ohio Innovation Fund.
Jeff Schumann is listed in a Venture Advisor capacity at Ohio Innovation Fund. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.
Principal
Ohio Innovation Fund
Check: $500K-$4M, as published by Ohio Innovation Fund.
Faith Voinovich invests or supports investments through Ohio Innovation Fund's published strategy: Back transformative, disruptive and breakthrough founders in AI, medtech, AR/VR, cybersecurity, SaaS and biotech, while providing hands-on support through key value inflection points.
Managing Partner
Cottonwood Technology Fund
Check: Cottonwood publishes a $1M-$3M first-investment range for seed-stage companies.
Dave Blivin contributes to Cottonwood Technology Fund's published strategy: Lead early rounds in patent-based hard-science and deep-technology companies in the U.S. Southwest and Northern Europe.
General Partner
Cottonwood Technology Fund
Check: Cottonwood publishes a $1M-$3M first-investment range for seed-stage companies.
Alain le Loux contributes to Cottonwood Technology Fund's published strategy: Lead early rounds in patent-based hard-science and deep-technology companies in the U.S. Southwest and Northern Europe.
Partner
Cottonwood Technology Fund
Check: Cottonwood publishes a $1M-$3M first-investment range for seed-stage companies.
Lee Rand contributes to Cottonwood Technology Fund's published strategy: Lead early rounds in patent-based hard-science and deep-technology companies in the U.S. Southwest and Northern Europe.
Advisor
Rock Health Capital
Check: Rock Health Capital does not publish a standard current check-size range on its official site.
Hylton Kalvaria is listed in a Advisor capacity at Rock Health Capital. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.
Advisor
Rock Health Capital
Check: Rock Health Capital does not publish a standard current check-size range on its official site.
Keith W. Anderson is listed in a Advisor capacity at Rock Health Capital. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.
Advisor
Rock Health Capital
Check: Rock Health Capital does not publish a standard current check-size range on its official site.
Monique Smith is listed in a Advisor capacity at Rock Health Capital. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.
Founder and General Partner
Rock Health Capital
Check: Rock Health Capital does not publish a standard current check-size range on its official site.
Bill Evans invests or supports investments through Rock Health Capital's published strategy: Invest in remarkable entrepreneurs working at the intersection of healthcare and technology to make healthcare massively better for every human being.
Principal
Rock Health Capital
Check: Rock Health Capital does not publish a standard current check-size range on its official site.
Sean Day invests or supports investments through Rock Health Capital's published strategy: Invest in remarkable entrepreneurs working at the intersection of healthcare and technology to make healthcare massively better for every human being.